Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 121 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Resminostat for maintenance treatment of patients with advanced stage mycosis fungoides or Sézary syndrome	Resminostat (4SC-201)	Cutaneous T-cell lymphoma (CTCL) , Mycosis fungoides or sezary syndrome	Haematological Cancer and Lymphomas , Skin Cancer	2024	View \| Download
Retifanlimab with carboplatin with paclitaxel for treating locally advanced or metastatic squamous cell anal carcinoma	Carboplatin (Paraplatin) , Paclitaxel (Taxol; paclitaxel albumin) , Retifanlimab (INCMGA00012; MGA-012)	Squamous cell anal carcinoma	Gastrointestinal Cancer	2024	View \| Download
Retifanlimab with chemotherapy for previously untreated metastatic non-small-cell lung cancer	Endocrine therapy , Ribociclib (Kisqali; LEE-011; ribociclib succinate)	Breast cancer , Non-small-cell lung cancer (NSCLC)	Breast Cancer , Lung and Respiratory Cancer	2024	View \| Download
Sarconeos for treating severe COVID-19 in people aged 45 years and over	Sarconeos (BIO101; BIO 101; BIO-101; Ruvembri)	COVID-19	Infectious Disease	2024	View \| Download
Sasanlimab with Bacillus Calmette-Guérin for treating high-risk non-muscle invasive bladder cancer	Bacillus Calmette-Guerin (BCG; BCG Tokyo-172; OncoTICE) , Sasanlimab (PF-06801591)	Bladder cancer	Urological Cancer	2024	View \| Download
Savolitinib with osimertinib for treating EGFR- mutated, MET-overexpressed advanced non-small-cell lung cancer	Osmertinib , Savolitinib (AZD6094)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2024	View \| Download
Secukinumab biosimilar for treating plaque psoriasis	Secukinumab biosimilar (BAT2306)	Plaque psoriasis	Dermatology	2024	View \| Download
Selumetinib (granule formulation) for treating neurofibromas type 1-related symptomatic, inoperable plexiform in children	Selumetinib (AZD6244; ARRY-142886)	Plexiform neurofibromas	Nephrology , Neurological Cancer	2024	View \| Download
Setmelanotide for treating acquired hypothalamic obesity in people 4 years and older	Setmelanotide (RM-493)	Hypothalamic obesity	Endocrine Nutritional and Metabolic Disorders	2024	View \| Download
Sibeprenlimab for treating Immunoglobulin A Nephropathy	Sibeprenlimab	Immunoglobulin A Nephropathy	Immunology , Nephrology	2024	View \| Download